Results 1 to 10 of about 44,644 (146)

Fibrodysplasia ossificans progressiva

open access: yesClinical Case Reports, 2023
Key Clinical Message Fibrodysplasia ossificans progressiva is a progressively debilitating condition associated with significant morbidity caused by heterotopic ossification. Recognition of the early signs of hallux valgus and painful soft tissue nodules
Chané Smit, André Uys
doaj   +7 more sources

Editorial of Special Issue “Fibrodysplasia Ossificans Progressiva: Studies on Disease Mechanism towards Novel Therapeutic Approaches”

open access: yesBiomedicines, 2022
The Special Issue on “Fibrodysplasia Ossificans Progressiva: Studies on Disease Mechanism towards Novel Therapeutic Approaches” has published interesting and useful review articles and original experimental articles on fibrodysplasia ossificans ...
Roberto Ravazzolo
doaj   +2 more sources

Fibrodysplasia Ossificans Progressiva: A rare case series

open access: yesJournal of Orthopaedic Reports, 2023
Background: Fibrodysplasia ossificans progressiva is a rare autosomal dominant connective tissue disorder with a prevalence of 2 per million individuals.
Lokesh kumar Sekaran   +3 more
doaj   +2 more sources

Early Recognition of Fibrodysplasia Ossificans Progressiva-Important For the Clinician [PDF]

open access: yesJournal of Nepal Medical Association, 2016
Fibrodysplasia ossificans progressiva is a rare disorder of heterotopic ossification. Procedures like biopsy and surgery are known to be aggravating factors in promoting heterotopic ossification Clues to clinical diagnosis may therefore be a great ...
Ankur Singh   +3 more
doaj   +4 more sources

Fibrodysplasia Ossificans Progressiva [PDF]

open access: yesBest Practice and Research in Clinical Rheumatology, 2008
Fibrodysplasia ossificans progressiva (FOP), a rare and disabling genetic condition of congenital skeletal malformations and progressive heterotopic ossification (HO), is the most catastrophic disorder of HO in humans. Episodic disease flare-ups are precipitated by soft tissue injury, and immobility is cumulative.
Robert J Pignolo   +2 more
exaly   +3 more sources

FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

open access: yesNational Journal of Medical Research, 2013
Fibrodysplasia ossificans progressiva is a rare genetic disease characterized by widespread soft tissue ossification and congenital stigmata of the extremities.
Mehul M Gosai   +4 more
doaj   +1 more source

Knowledge and awareness about fibrodysplasia ossificans progressiva among dental students

open access: yesJournal of Advanced Pharmaceutical Technology & Research, 2022
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder which is autosomal dominant distinguished by congenital malformations of large toes and flare ups, etc. It is a disorder of connective tissue, with heterotopic ossifications seen with
L Akshayaa   +3 more
doaj   +1 more source

Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases

open access: yesOrphanet Journal of Rare Diseases, 2018
Background Rare diseases are a global public health concern, affecting an estimated 350 million individuals. Only 5% of approximately 7000 known rare diseases have a treatment, and only about half have a patient advocacy organization.
Susan Stein   +8 more
doaj   +1 more source

Fibrodysplasia ossificans progressiva: case report [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2000
Fibrodysplasia ossificans progressiva is a rare genetic disease characterized by widespread soft tissue ossification and congenital stigmata of the extremities.
ANAMARLI NUCCI   +4 more
doaj   +1 more source

FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

open access: yesBritish Journal of Anaesthesia, 1990
A 14-yr-old boy with fibrodysplasia ossificans progressiva (FOP) presented for surgery for bilateral division of his ossified masseter muscles. Patients with FOP may present problems to the anaesthetist, including difficulties with tracheal intubation, restrictive pulmonary disease and abnormalities of cardiac conduction.
M C, Newton, P W, Allen, D C, Ryan
openaire   +2 more sources

Home - About - Disclaimer - Privacy